These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 25640159)

  • 1. PDE4 inhibition reduces neointima formation and inhibits VCAM-1 expression and histone methylation in an Epac-dependent manner.
    Lehrke M; Kahles F; Makowska A; Tilstam PV; Diebold S; Marx J; Stöhr R; Hess K; Endorf EB; Bruemmer D; Marx N; Findeisen HM
    J Mol Cell Cardiol; 2015 Apr; 81():23-33. PubMed ID: 25640159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PDE4 inhibitor, roflumilast protects cardiomyocytes against NO-induced apoptosis via activation of PKA and Epac dual pathways.
    Kwak HJ; Park KM; Choi HE; Chung KS; Lim HJ; Park HY
    Cell Signal; 2008 May; 20(5):803-14. PubMed ID: 18276108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epac1 Deficiency Attenuated Vascular Smooth Muscle Cell Migration and Neointimal Formation.
    Kato Y; Yokoyama U; Yanai C; Ishige R; Kurotaki D; Umemura M; Fujita T; Kubota T; Okumura S; Sata M; Tamura T; Ishikawa Y
    Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2617-25. PubMed ID: 26427796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphodiesterase type 4 expression and anti-proliferative effects in human pulmonary artery smooth muscle cells.
    Growcott EJ; Spink KG; Ren X; Afzal S; Banner KH; Wharton J
    Respir Res; 2006 Jan; 7(1):9. PubMed ID: 16423283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphodiesterase-4 inhibition augments human lung fibroblast vascular endothelial growth factor production induced by prostaglandin E2.
    Ikari J; Michalski JM; Iwasawa S; Gunji Y; Nogel S; Park JH; Nelson AJ; Farid M; Wang X; Schulte N; Basma H; Toews ML; Feghali-Bostwick C; Tenor H; Liu X; Rennard SI
    Am J Respir Cell Mol Biol; 2013 Oct; 49(4):571-81. PubMed ID: 23656623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulator of G-Protein Signaling 5 Prevents Smooth Muscle Cell Proliferation and Attenuates Neointima Formation.
    Daniel JM; Prock A; Dutzmann J; Sonnenschein K; Thum T; Bauersachs J; Sedding DG
    Arterioscler Thromb Vasc Biol; 2016 Feb; 36(2):317-27. PubMed ID: 26663397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of roflumilast, a phosphodiesterase-4 inhibitor, on hypoxia- and monocrotaline-induced pulmonary hypertension in rats.
    Izikki M; Raffestin B; Klar J; Hatzelmann A; Marx D; Tenor H; Zadigue P; Adnot S; Eddahibi S
    J Pharmacol Exp Ther; 2009 Jul; 330(1):54-62. PubMed ID: 19386793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of endoplasmic reticulum stress inhibits neointima formation after vascular injury.
    Ishimura S; Furuhashi M; Mita T; Fuseya T; Watanabe Y; Hoshina K; Kokubu N; Inoue K; Yoshida H; Miura T
    Sci Rep; 2014 Nov; 4():6943. PubMed ID: 25373918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct Inhibitory Effect of the PDE4 Inhibitor Roflumilast on Neutrophil Migration in Chronic Obstructive Pulmonary Disease.
    Dunne AE; Kawamatawong T; Fenwick PS; Davies CM; Tullett H; Barnes PJ; Donnelly LE
    Am J Respir Cell Mol Biol; 2019 Apr; 60(4):445-453. PubMed ID: 30395484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-talk between PKA-Cβ and p65 mediates synergistic induction of PDE4B by roflumilast and NTHi.
    Susuki-Miyata S; Miyata M; Lee BC; Xu H; Kai H; Yan C; Li JD
    Proc Natl Acad Sci U S A; 2015 Apr; 112(14):E1800-9. PubMed ID: 25831493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salt-Inducible Kinase 3 Promotes Vascular Smooth Muscle Cell Proliferation and Arterial Restenosis by Regulating AKT and PKA-CREB Signaling.
    Cai Y; Wang XL; Lu J; Lin X; Dong J; Guzman RJ
    Arterioscler Thromb Vasc Biol; 2021 Sep; 41(9):2431-2451. PubMed ID: 34196217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-inflammatory and immunomodulatory potential of the novel PDE4 inhibitor roflumilast in vitro.
    Hatzelmann A; Schudt C
    J Pharmacol Exp Ther; 2001 Apr; 297(1):267-79. PubMed ID: 11259554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The unrecognized effects of phosphodiesterase 4 on epithelial cells in pulmonary inflammation.
    Konrad FM; Bury A; Schick MA; Ngamsri KC; Reutershan J
    PLoS One; 2015; 10(4):e0121725. PubMed ID: 25909327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cleaved high-molecular-weight kininogen inhibits neointima formation following vascular injury.
    Daniel JM; Reich F; Dutzmann J; Weisheit S; Teske R; Gündüz D; Bauersachs J; Preissner KT; Sedding DG
    Thromb Haemost; 2015 Aug; 114(3):603-13. PubMed ID: 26063414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BET bromodomain-containing epigenetic reader proteins regulate vascular smooth muscle cell proliferation and neointima formation.
    Dutzmann J; Haertlé M; Daniel JM; Kloss F; Musmann RJ; Kalies K; Knöpp K; Pilowski C; Sirisko M; Sieweke JT; Bauersachs J; Sedding DG; Gegel S
    Cardiovasc Res; 2021 Feb; 117(3):850-862. PubMed ID: 32353113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional regulation of VCAM-1 expression by tumor necrosis factor-alpha in human tracheal smooth muscle cells: involvement of MAPKs, NF-kappaB, p300, and histone acetylation.
    Lee CW; Lin WN; Lin CC; Luo SF; Wang JS; Pouyssegur J; Yang CM
    J Cell Physiol; 2006 Apr; 207(1):174-86. PubMed ID: 16288471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roflumilast inhibits leukocyte-platelet interactions and prevents the prothrombotic functions of polymorphonuclear leukocytes and monocytes.
    Totani L; Amore C; Di Santo A; Dell'Elba G; Piccoli A; Martelli N; Tenor H; Beume R; Evangelista V
    J Thromb Haemost; 2016 Jan; 14(1):191-204. PubMed ID: 26484898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roflumilast inhibits leukocyte-endothelial cell interactions, expression of adhesion molecules and microvascular permeability.
    Sanz MJ; Cortijo J; Taha MA; Cerdá-Nicolás M; Schatton E; Burgbacher B; Klar J; Tenor H; Schudt C; Issekutz AC; Hatzelmann A; Morcillo EJ
    Br J Pharmacol; 2007 Oct; 152(4):481-92. PubMed ID: 17704822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Roflumilast partially reverses smoke-induced mucociliary dysfunction.
    Schmid A; Baumlin N; Ivonnet P; Dennis JS; Campos M; Krick S; Salathe M
    Respir Res; 2015 Oct; 16():135. PubMed ID: 26521141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epac1 is upregulated during neointima formation and promotes vascular smooth muscle cell migration.
    Yokoyama U; Minamisawa S; Quan H; Akaike T; Jin M; Otsu K; Ulucan C; Wang X; Baljinnyam E; Takaoka M; Sata M; Ishikawa Y
    Am J Physiol Heart Circ Physiol; 2008 Oct; 295(4):H1547-55. PubMed ID: 18689492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.